中国临床保健杂志2024，Vol.27Issue(1)：43-46,4.DOI:10.3969/J.issn.1672-6790.2024.01.009
《中国老年代谢综合征药物治疗专家共识(2022)》解读
Interpretation of Expert Consensus on Drug Treatment for Metabolic Syndrome in the Elderly in China(2022)
詹俊鲲 1刘幼硕1
作者信息
- 1. 中南大学湘雅二医院老年医学科/老年内分泌科,中南大学衰老与老年疾病研究所,长沙 410011
- 折叠
摘要
Abstract
Metabolic syndrome in the elderly refers to a cluster of metabolic disturbances,characterized by a high comorbidity incidence,varied clinical presentations,intricate mechanisms,and the involvement of polypharmacy,which elevates the risk of adverse drug reactions.Metabolic syndrome severely undermines the quality of life and health among the elderly,placing a significant burden on healthcare system and society in China.Expert Consensus on Drug Treatment for Metabolic Syndrome in the Elderly in China(2022)thoroughly reviewed and summarized the diagnostic criteria and therapeutic objectives for metabolic syndrome in the elderly,provided the latest medications and their inter-actions,and offered ten recommendation points.This document interprets the key points of the consensus,particularly in terms of pharmacological treatment,and aims to provide relevant references for the decision-making process in the phar-macological management and health care for elderly individuals with metabolic syndrome.关键词
代谢综合征/慢性病共病/药物疗法/生活质量/老年人Key words
Metabolic syndrome/Multiple chronic conditions/Drug therapy/Quality of life/Aged引用本文复制引用
詹俊鲲,刘幼硕..《中国老年代谢综合征药物治疗专家共识(2022)》解读[J].中国临床保健杂志,2024,27(1):43-46,4.
